Clinical Trials Browser

Phase NA × Ovarian Neoplasms × pembrolizumab × Clear all

NCT05368207 2024-03-13

Pemb-HT

Phase NA Active not recruiting

Ovarian Neoplasms, Carcinoma, Small Cell